Advancing treatments for rare diseases together

EspeRare CEO advocates for Patient-Centered Drug Development at BioPharma Leaders Conference in Boston, US

21Oct

Caroline Kant, Executive Director of EspeRare, will participate in the BioPharma Executive Leaders Conference in Boston on October 29, 2024. She will join a panel to discuss the importance of patient-centric approaches in development of therapeutic solutions. This conference presents a valuable opportunity for top global leaders to connect, collaborate, and exchange ideas aimed at advancing novel technologies and innovative treatments that can enhance patient outcomes.

Event Details:
The BioPharma Executive Leaders Conference, hosted by Longwood Healthcare Leaders, will take place on October 28-29, 2024, at the Mandarin Oriental Hotel in Boston, US. The event gathers biotech and pharma CEOs, R&D heads, academics, and investors for off-the-record discussions that foster transparency and innovation in drug development.

For more information on the event follow the link : https://www.longwoodhealthcareleaders.com/bostonceo